Pancreatic cancer has the lowest survival rate of cancer in Europe. Beyond the need to improve patient comfort, non-invasive approaches must also address the need for viable alternative care for this cancer. The MAGCELL project aims to develop methodologies and protocols, an experimental device and knowledge to detect and measure the release of magneto-induced heat from a single magnetic nanoparticle, and to evaluate the magneto-induced effects (hyperthermia or mechanical) of these effects on a cell or single cell. The project involves four academic partners (CNRS, Université de Montpellier, INSERM, ENSCM) through 2 laboratories (CBS: Montpellier Centre for Structural Biochemistry — UMR No 5048, and ICGM: Charles Gerhardt Institute — UMR 5253) and 1 private partners: — CELL CONSTRAINT & CANCER The measurements and effects will be developed on magnetic nanoparticles provided by the partner ICGM and CC&C for a study carried out by the CBS on tumour cells of the pancreas. This project will constitute an acquisition of academic knowledge, an experimental device accessible to economic actors interested in these issues in a European landscape still unstructured in physical oncology on this type of cancer.